NASDAQ · Healthcare · Biotechnology
Eikon Therapeutics, Inc. Common Stock
EIKN
Eikon Therapeutics, Inc. CEO Roger Perlmutter · Market cap $392.0M.
$7.24
-0.30 · -3.98%
52w hi $17.4052w lo $7.02
Off 52w high 38.5%
73
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
8
4 strong · 4 notable
Analyst consensus
Sell
Avg PT $5.00
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 03 | Column Group IV GP, LP | Buy | 89,200 | $11.56 | +$1.03M | 73 | |
| Feb 06 | Column Group IV GP, LP | Buy | 630,881 | $18.00 | +$11.36M | 76 | |
| Feb 06 | Column Group IV GP, LP | Buy | 1,437,323 | $18.00 | +$25.87M | 73 | |
| Feb 06 | Column Group IV GP, LP | Buy | 49,556 | $18.00 | +$892K | 67 | |
| Feb 04 | Josh Wolfe | Buy | 138,888 | $18.00 | +$2.50M | 88 | |
| Feb 04 | Kenneth C Frazier | Buy | 111,111 | $18.00 | +$2.00M | 84 | |
| Feb 04 | Foresite Capital Management IV, LLC | Buy | 55,555 | $18.00 | +$1000K | 72 | |
| Feb 04 | Lux Venture Partners V, LLC | Buy | 138,888 | $18.00 | +$2.50M | 88 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct